Search Results 621-630 of 16792 for Bioavailability

  1. Laboratories - Mayo Clinic Research

    B. B-Cell Lymphoproliferative Disorders: Susan L. Slager · Biliary Epigenetics and Regenerative Medicine: Robert C. Huebert · Bioelectronics Neurophysiology ...

  2. Myelodysplastic Syndromes Clinical Trials - Mayo Clinic Research

    CCS1477 is a potent, selective and orally bioavailable inhibitor of the bromodomain of p300 and CBP, critical transcriptional co-activators of genes that drive ...

  3. Digestive Diseases Clinical Trials - Medical Professionals

    One uncontrolled, unpublished study suggests that a footstool improved bowel symptoms in nearly 98% of 153 constipated participants. The purpose of this study ...

  4. LS1681: A Study of AR160 in Treating Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of tumor cells, either by ...

  5. Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Twice Daily on Nutritional Status in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

    To evaluate the safety and effectiveness of oral nutritional therapy Serum-Derived Bovine Immunoglobulin (SBI) on nutritional status, epithelial barrier ...

  6. A Study to Identify and Characterize Neurophysiological Biomarkers for Progression of Neurodegenerative Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Long-term Extension Study of Ulviprubart (ABC008) in Subjects with Inclusion Body Myositis - Mayo Clinic

    About this study. ABC008-IBM-202 is an open-label, multicenter study to evaluate the safety and efficacy of long-term administration of ulviprubart (ABC008) ...

  8. Metformin Hydrochloride and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

    Metformin Hydrochloride and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · Share ...

  9. Transplant Organ Genomics to Help Prevent Rejection in Kidney Transplant Recipients – RNA-seq Signature Validation - Mayo Clinic

    About this study. The purpose of this study is to validate the use of an RNA-seq based peripheral blood assay in renal transplant recipients in adult kidney ...

  10. Neural Circulatory Control and SUDEP Risk. - Mayo Clinic

    About this study. The investigators believe epilepsy alters the way the body controls blood pressure, heart rate and breathing, and these changes increase ...